分享好友 法规首页 频道列表

2002/67/EC 关于含奎宁及咖啡因的食品标识规定(On the labelling of foodstuffs containing quinine, and of foodstuffs con

2011-04-03 11:138470

  THE COMMISSION OF THE EUROPEAN COMMUNITIES,

  Having regard to the Treaty establishing the European Community,

  Having regard to Directive 2000/13/EC of the European Parliament and of the Council, of 20 March 2000, on the approximation of the laws of the Member States relating to the labelling, presentation and advertising of foodstuffs(1), as amended by Commission Directive 2001/101/EC(2), and in particular Article 4(2) and (3) thereof,

  Whereas:

  (1) Quinine and caffeine are used in the production or preparation of certain foodstuffs, either as a flavouring or, in the case of caffeine, as an ingredient. For most consumers, the consumption of these substances in moderation is unlikely to present any health risks.

  (2) According to the conclusions of the Scientific Committee for Food, there is no objection from the point of view of toxicology to the continued use of quinine at a certain maximum level in bitter drinks. However, consumption of quinine may be counter-indicated for certain people for medical reasons, or because they are hypersensitive to the substance.

  (3) As far as caffeine is concerned, the Scientific Committee for Food, in its opinion of 21 January 1999 on caffeine and other substances used as ingredients in "energy drinks", concluded that, for adults, apart from pregnant women, the contribution of "energy drinks" to the total consumption of caffeine did not appear to be a cause for concern, assuming that "energy drinks" replace other sources of caffeine. However, for children, an increase in the daily intake of caffeine to a certain level of consumption per day may bring about temporary changes in behaviour, such as increased excitability, irritability, nervousness or anxiety. In addition, for pregnant women, the Committee's view is that moderation of caffeine intake is advisable.

  (4) These findings make it necessary to provide labelling which gives the consumer clear information on the presence or otherwise of quinine or caffeine in a foodstuff and, in the case of caffeine, to provide a warning message and an indication of the amount of caffeine, where this is in excess of a specific level, in beverages which do not naturally contain caffeine.

  (5) Directive 2000/13/EC does not provide for compulsory and specific mention of flavourings in the list of ingredients. Quinine or caffeine, used as a flavouring, might as a result not be listed by name in the ingredients. Moreover, even where caffeine is mentioned as such in the list of ingredients, there is no requirement to indicate whether the level is high.

  (6) Some Member States have enacted national legislation making it compulsory to mention the presence of quinine and/or caffeine on the labels of foodstuffs which contain these substances, in certain cases also stating the amount of caffeine, with a warning. The existence and application of different national legislation causes technical problems for intra-Community trade in the foodstuffs concerned.

  (7) It is therefore necessary, with a view to providing information for all consumers throughout the Community and to facilitating the free movement of the products in question, to introduce harmonised provisions to apply to foodstuffs containing quinine and those containing caffeine. These provisions must make it necessary to include compulsory particulars on the label in addition to those set out in Directive 2000/13/EC.

  (8) The measures provided for in this Directive are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

  HAS ADOPTED THIS DIRECTIVE:

  Article 1

  By derogation from Article 6(6), second subparagraph, third indent, of Directive 2000/13/EC, quinine and/or caffeine used as a flavouring in the production or preparation of a foodstuff must be mentioned by name in the list of ingredients indicated in Article 3(1)(2), of Directive 2000/13/EC, immediately after the term "flavouring".

  Article 2

  1. Where a beverage which is intended for consumption without modification, or after reconstitution of the concentrated or dried product, contains caffeine, from whatever source, in a proportion in excess of 150 mg/l, the following message must appear on the label in the same field of vision as the name under which the product is sold: "High caffeine content".

  This message shall be followed, in brackets and in accordance with Article 13(2) of Directive 2000/13/EC, by the caffeine content expressed in mg/100 ml.

  2. Paragraph 1 shall not apply to beverages based on coffee, tea or coffee or tea extract where the name under which the product is sold includes the term "coffee" or "tea".

  Article 3

  1. The Member States shall permit trade in products which comply with this Directive as of 1 July 2003.

  2. The Member States shall prohibit trade in products which do not comply with this Directive as of 1 July 2004.

  However, products which do not comply with this Directive and which were labelled before 1 July 2004 shall be authorised while stocks last.

  Article 4

  The Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive no later than 30 June 2003. They shall forthwith inform the Commission thereof.

  When the Member States adopt these provisions, these shall contain a reference to this Directive or shall be accompanied by such reference at the time of their official publication. The procedure for such references shall be adopted by Member States.

  Article 5

  This Directive shall enter into force on the 20th day following its publication in the Official Journal of the European Communities.

  Article 6

  This Directive is addressed to the Member States.

  Done at Brussels, 18 July 2002.

  For the Commission

  David Byrne

  Member of the Commission

  (1) OJ L 109, 6.5.2000, p. 29.

  (2) OJ L 310, 28.11.2001, p. 19.

更多关于欧盟食品标签法规的内容,请点击欧盟食品标签法规汇总



反对 0
举报 0
收藏 0
打赏 0
常州市市场监督管理局等部门关于印发《常州市规范特殊医学用途配方食品管理促进产业高质量发展的实施方案》的通知 (常市监〔2025〕30号)
为贯彻落实《关于进一步规范特殊医学用途配方食品管理促进产业高质量发展的指导意见》(苏市监〔2024〕247号)文件精神,结合我市实际情况,特制定实施方案,加强我市特殊医学用途配方食品(以下简称“特医食品”)的规范管理,促进产业高质量发展。

2025-06-17511

国家市场监督管理总局对十四届全国人大三次会议第3840号建议的答复|关于加快制定特殊医学用途配方食品流通使用管理办法的建议 (国市监议〔2025〕24号)
提出的《关于加快制定特殊医学用途配方食品流通使用管理办法的建议》收悉。现答复如下。

2025-06-05708

市场监管总局发布肝病、胃肠道吸收障碍 特定全营养配方食品临床试验技术指导文件
近日,市场监管总局发布《特定全营养配方食品临床试验技术指导原则 肝病》《特定全营养配方食品临床试验技术指导原则 胃肠道吸收障碍》两项技术指导文件,旨在指导企业和临床试验机构规范相应类别特定全营养配方食品的临床试验过程,保证数据及结果的科学、真实、可靠,提高注册审评审批效率,保护受试者、消费者的安全和权益,并保障产品安全性、营养充足性和临床有效性。

2025-05-27601

新疆规范"三品一械"广告 守护消费者健康权益
近日新疆出台的"三品一械"广告合规指引,对药品、医疗器械、保健食品和特殊医学用途配方食品广告发布提出了明确规范要求,为消费者筑起了一道安全防线。

2025-05-20974

新疆药品、医疗器械、保健食品、特殊医学用途配方食品广告合规指引
为进一步规范药品、医疗器械、保健食品、特殊医学用途配方食品(以下简称“三品一械”)广告发布行为,保护消费者合法权益,促进广告业健康有序发展,根据《中华人民共和国广告法》《互联网广告管理办法》《药品、医疗器械、保健食品、特殊医学用途配方食品广告审查管理暂行办法》等法律法规的有关规定,结合本地实际,制定本合规指引。

2025-05-15829

特殊医学用途婴儿配方食品按新国标注册问答
特殊医学用途婴儿配方食品按新国标注册问答。

2025-04-24866

食品标准法规动态回顾(2025-3-29至2025-4-3)
食品伙伴网本周标准法规动态回顾内容涉及标准和法规两个方面。标准方面,3 项特定全营养配方食品临床试验技术指导原则国标征求意见。法规方面,国家市场监管总局废止和修改部分规章,对《网络食品安全违法行为查处办法》《食品安全抽样检验管理办法》等规章作出修改,此外,多地发布食品相关监管通知、条例,如广东加强从业人员健康检查、开展质量监督抽查,湖北出台农产品质量安全条例等。

2025-04-03892

婴幼儿配方奶粉新规出台 原料管理全面升级
国家市场监管总局近日发布新规,进一步加强婴幼儿配方乳粉原料管理。新规明确禁止使用已符合营养标准的复合配料作为原料,要求使用基粉的企业必须在两年内改用具备婴幼儿配方乳粉生产资质的企业产品。

2025-04-02930